The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
The flip of that was remdesivir. So whereas steroids were very beneficial late in the course of the disease, medications like Remdesivir, it's not an anti-inflammatory, but rather an antiviral, it prevents the viral replication. The opposite was found. Remdesivir was much more efficacious early in the course of the disease, and not so much so for those patients on the ventilator.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.